The prognosis of patients with cardiac amyloidosis is affected by their cardiac condition, the extracardiac involvement and the modality of treatment of the underlying disease. Another predictor ...

Definite diagnosis is based on endomyocardial biopsy and treatment of cardiac amyloidosis is a challenge. Heart transplantation, although controversial, has demonstrated survival benefit.

explains what cardiac amyloidosis is, why knowing the type of amyloid is key to treatment, and what's on the horizon to help ...

This causes serious, wide-ranging symptoms, including heart disease, kidney failure, and nerve damage. Amyloidosis treatment involves addressing the symptoms, including those of ATTR cardiac ...

In September 2001 she had severe gastrointestinal symptoms and deposits of AA ... could be an important therapy for the treatment of AA amyloidosis secondary to rheumatic disease.

Along with treatment, complementary therapy ... The research cited an older study that found green tea reduced cardiac-related amyloidosis symptoms and amyloid plaques. Still, more research ...

After 1 July 2009, fewer transplant recipients had Mayo stage III cardiac ... based treatment or participation in clinical trials. Cohen AD, Comenzo RL . Systemic light-chain amyloidosis: advances ...

Findings from this collaboration have the potential to impact not only amyloidosis but also other cardiac conditions, where non-invasive, information-rich diagnosis and monitoring are crucial.

This dual-modality technique could enable the detection of functional changes in amyloidosis and offer a better method for tracking disease progression & treatment response over time ... to impact not ...